The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lebuhn Robert since 2006.
The trader's CIK number is 1007931.
At the time of the last reporting, Lebuhn Robert was the Director of Enzon Pharmaceuticals, Inc.. (stock ticker symbol ENZN).
Also see all insider trading activities at Enzon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | ENZN | 0 | $0 | 55,926 | $96,086 | 0 | $0 |
| 2012 | ENZN | 0 | $0 | 7,753 | $51,026 | 0 | $0 |
| 2011 | ENZN | 0 | $0 | 18,702 | $200,800 | 0 | $0 |
| 2010 | ENZN | 0 | $0 | 10,000 | $104,980 | 3,173 | $0 |
| 2009 | ENZN | 0 | $0 | 0 | $0 | 4,279 | $0 |
| 2008 | ENZN | 0 | $0 | 0 | $0 | 5,532 | $0 |
| 2007 | ENZN | 0 | $0 | 0 | $0 | 42,360 | $117,480 |
| 2006 | ENZN | 0 | $0 | 0 | $0 | 1,255 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-09-17 | ENZN | Sale | 34,807 | 1.74 | 60,459 |
| 2013-09-19 | ENZN | Sale | 21,119 | 1.69 | 35,627 |
| 2012-08-14 | ENZN | Sale | 5,820 | 6.58 | 38,307 |
| 2012-08-10 | ENZN | Sale | 1,933 | 6.58 | 12,719 |
| 2011-06-01 | ENZN | Sale | 8,702 | 10.57 | 91,980 |
| 2011-02-22 | ENZN | Sale | 10,000 | 10.88 | 108,820 |
| 2010-08-26 | ENZN | Sale | 10,000 | 10.50 | 104,980 |
| 2010-07-02 | ENZN | Option Ex | 3,173 | .00 | 0 |
| 2009-07-02 | ENZN | Option Ex | 3,173 | .00 | 0 |
| 2009-07-03 | ENZN | Option Ex | 1,106 | .00 | 0 |
| 2008-07-01 | ENZN | Option Ex | 1,255 | .00 | 0 |
| 2008-07-02 | ENZN | Option Ex | 3,172 | .00 | 0 |
| 2008-07-03 | ENZN | Option Ex | 1,105 | .00 | 0 |
| 2007-07-01 | ENZN | Option Ex | 1,255 | .00 | 0 |
| 2007-07-03 | ENZN | Option Ex | 1,105 | .00 | 0 |
| 2007-01-02 | ENZN | Option Ex | 40,000 | 2.94 | 117,480 |
| 2006-07-01 | ENZN | Option Ex | 1,255 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lebuhn Robert (Director of Enzon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.